-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901.O2.6 901. Health Services and Quality Improvement – Non-Malignant Conditions: Raising the bar in Anemia, Bleeding, and Thrombotic Disorders

Symposia: Health Services and Quality Improvement - Non-Malignant Conditions Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Bleeding and Clotting, bleeding disorders, Sickle Cell Disease, Clinical Practice (Health Services and Quality), hemophilia, Hemoglobinopathies, Diseases, Maternal Health
Sunday, December 10, 2023: 4:30 PM-6:00 PM
Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
Jason A Freed, MD, Beth Israel Deaconess and Prarthana Parthasarathy, MD, Riley Hospital for Children at Indiana University
No relevant conflicts of interest to declare.
A plethora of hematology care. From use of IV iron, to inherited bleeding disorders, menstrual bleeding in SCD, and thrombosis management in cancer patients.
4:30 PM

Chiara Alessandra Cella, MD, PhD1*, Nicola Fazio1*, Florian Lordick2*, Vincenzo Bagnardi3,4*, Samuele Frassoni4*, Lorenzo Gervaso1,5*, Carmine Valenza6*, Iztok Hozo, PhD7* and Benjamin Djulbegovic, MD8

1Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milano, Italy
2University Cancer Center Leipzig (UCCL), University Hospital Leipzig, Leipzig, Germany, Leipzig, Germany
3European Institute of Oncology, Milan, ITA
4Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milano, Italy
5Molecular Medicine Department, University of Pavia, Pavia, Italy, Pavia, Italy
6Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milano, Italy
7Indiana University Northwest, Gary
8Medical University of South Carolina, Charleston, SC

4:45 PM

Ming Y Lim, MBBChir1, Vasee Sivaloganathan2* and Sara E Simonsen2*

1Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT
2University of Utah, Salt Lake City

5:00 PM

MariaElisa Mancuso, MD1*, Chiara Biasoli, MD2*, Renato Marino, MD3*, Andrea Buzzi4*, Daniele Preti5*, Sara Bendinelli, PhD6*, Rosaria Tempre, MSc6*, Elena Pompeo6*, Luigi Sannino, MSc6*, Giacomo Siri, PhD7* and Giancarlo Castaman, MD8*

1Centre for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Italy
2Centro Emofilia - U.O.C. Medicina Trasfusionale - Dipartimento Patologia, Clinica Ospedale M. Bufalini, Cesena, Italy
3S.S.D. Centro Emofilia e Trombosi, Ospedale Policlinico, Bari, ITA
4Fondazione Paracelso, milano, Italy
5Federazione Associazioni Emofilici, Milano, Italy
6Roche S.p.a, Monza, Italy
7Alira Health S.r.l., Milano, Italy
8SOD Malattie Emorragiche, AOU Careggi, Firenze, Italy

5:15 PM

Stacey Fedewa, PhD, MPH1*, Amanda B. Payne, PhD, MPH2, Lorraine Cafuir, MD3, Duc Quang Tran, MD, MSc3, Ana G. Antun, MD4 and Christine Kempton, MD3

1Department of Hematology and Medical Oncology and Hemophilia of Georgia Center for Bleeding & Clotting Disorders at Emory, Emory University, Atlanta, GA
2Centers For Disease Control and Prevention, Atlanta, GA
3Emory University, Atlanta, GA
4Emory University, Decatur, GA

5:30 PM

Neha Bhasin, MD1,2,3, Gillian Rush, CRC1*, John J Strouse, MD, PhD4,5, Kim Moffatt-Bazile, NP3,6*, Rania E Mohamed, CRC4*, Seethal A Jacob, MD, MS7,8, Bindu Kanathezhath Sathi, MD3,9, Gayle M Smink, MD, MPH8,10, Corinna L. Schultz, MD11, Nicole DiVirgilio, CRC12*, Elliott P. Vichinsky, MD1,13, Maria C Velez, MD8,14*, Robert Hagar, MD3,15, Maa-Ohui Quarmyne, MD, MS16, Ugochi Ogu, MD17* and Marsha Treadwell, PhD1,3,8

1Department of Pediatrics, Division of Hematology, University of California San Francisco Benioff Children's Hospital, Oakland, CA
2FWGBD, WGSCD Learning Action Network Clinical Care Subcommittee, Montclair, NJ
3Pacific Sickle Cell Regional Collaborative (PSCRC), Oakland, CA
4Department of Medicine, Division of Hematology, Duke University School of Medicine, Durham, NC
5FWGBD, WGSCD Learning Action Network’s Clinical Care Subcommittee, Montclair, CA
6Children's Hospital Oakland, Oakland, CA
7Department of Pediatrics, Division of Hematology Oncology, Riley Hospital for Children, Indianapolis, IL
8FWGBD, WGSCD Learning Action Network’s Clinical Care Subcommittee, Montclair, NJ
9Hematology/Oncology, Valley Children's Hospital, Madera, CA
10Department of Pediatrics, Division of Hematology Oncology, Penn State University, Hershey, PA
11Center for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE
12Center for Cancer and Blood Disorders, Nemours Children’s Health, Wilmington, DE
13Pacific Sickle Cell Regional Collaborative (PSCRC), Oakland
14Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital New Orleans, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA
15Department of Pediatrics, Division of Hematology, University of California San Francisco Benioff Children's Hospitals, Oakland, CA
16Center of Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ
17Division of Hematology/Oncology, University of Tennessee Health Science Center Center for Sickle Cell Disease, Memphis, TN

5:45 PM

Richard C. Godby, MD, Sarah A. Chase*, Ronald S. Go, MD and Chelsee J. Jensen*

Mayo Clinic, Rochester, MN

*signifies non-member of ASH